Objective
Objectives:
The lungs are protected against enzymic damage by protease inhibitors, and principally by a1-antitrypsin. The overwhelming of these inhibitors as occurs in the genetic deficiency of a1-antitrypsin, gives cumulative destruction of lung elasticity with eventual development of emphysema. In order to pursue strategies for the prevention of this progression we need to understand the precise mechanism of protease inhibition. We now know the structure of a1-antitrypsin and can confidently deduce how the protease and inhibitor initially interact but the key step, the formation of the final irreversible complex, is still a matter of conjecture.
To determine the precise molecular mechanism involved we plan a combination of: 1) a crystallographic approach to give the structural relationships in the complex,
2) an NMR approach to show the bonding mechanism involved.
The lungs are protected against enzymic damage by protease inhibitors, and principally by alpha-1-antitrypsin. The overwhelming of these inhibitors as occurs in the genetic deficiency of alpha-1-antitrypsin, gives cumulative destruction of lung elasticity with eventual development of emphysema. In order to pursue strategies for the prevention of this progression we need to understand the precise mechanism of protease inhibition. We now know the structure of alpha 1-antitrypsin and can confidently deduce how the protease and inhibitor initially interact but the key step, the formation of the final irreversible complex, is still a matter of conjecture.
To determine the precise molecular mechanism involved we plan a combinationof:
1) a crystallographic approach to give the structural relationships in the complex;
2) an NMR approach to show the bonding mechanism involved.
To achieve this a series of recombinants of alpha-1-antitrypsin and proteases(trypsin and chymotrypsin) will be prepared with substitutions in the catalytic triad of the proteases and of the residues in alpha-1-antitrypsin modelled to interact with them. These recombinants together with other strategies make crystallisation of the complex feasible though not certain. The certain result will follow from 13C and 15N labelling of recombinants that will allow the characterisation of spatial and chemical distortion at the active/reactive sites by NMR. This will require the new technique of magic angle spinning NMR for which there is special expertise and facilities in Leiden. This application then is for support for a study bringing together experienced groups in the structure and function of alpha-1-antitrypsin from the UK, with the expertise in NMR available in the Netherlands. The overall aim is clear and achievable - to understand the mechanism by which alpha1-antitrypsin and other serpins formirreversible complexes with inflammatory proteases
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
CB2 2PT CAMBRIDGE
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.